Publications by authors named "Mary Gamal"

Claim this Profile
R
Rare disease challenges and potential actions in the Middle East.
Ahmad Nader Fasseeh, Nada Korra, Ahmed Aljedai, Ahmed Seyam, Hajer Almudaiheem, Mary Gamal

Int J Equity Health· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt.
Ahmad N Fasseeh, Nada Korra, Baher Elezbawy, Amal S Sedrak, Mary Gamal

J Egypt Public Health Assoc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt.
Mary Gamal, Amal Samir Sedrak, Gihan Hamdy Elsisi, Ahmed Elagamy, Ahmed Seyam

Glob J Qual Saf Healthc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region.
Baher Elezbawy, Mohamed Farghaly, Atlal Al Lafi, Mary Gamal, Mirna Metni

Value Health Reg Issues· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Framework for developing cost-effectiveness analysis threshold: the case of Egypt.
Ahmad N Fasseeh, Nada Korra, Baher Elezbawy, Amal S Sedrak, Mary Gamal

J Egypt Public Health Assoc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap toward implementing health technology assessment in Egypt.
Ahmad Nader Fasseeh, Baher Elezbawy, Mary Gamal, Ahmed Seyam, Asmaa Abourawash

Front Public Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt.
Baher Elezbawy, Ahmad Nader Fasseeh, Bertalan Németh, Mary Gamal, Mariam Eldebeiky

BMC Med Inform Decis Mak· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Institutionalizing health technology assessment in Egypt: Situational analysis and roadmap.
Pilar Pinilla-Dominguez, Shorouk Taha, Hugh McGuire, Ahmed Elagamy, Amal Sedrak, Mary Gamal

Front Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.
Baher Elezbawy, Ahmad Nader Fasseeh, Amal Sedrak, Randa Eldessouki, Mary Gamal

J Pharm Policy Pract· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4 (CD184) expression on stem cell harvest and CD34 cells post-transplant.
Inas Asfour, Hanaa Afify, Shaza Elkourashy, Maryse Ayoub, Gihan Kamal, Mary Gamal

Hematol Oncol Stem Cell Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis